Company: XERI
Filing Date: 2025-10-02
Form Type: 10-K
Source: 0001477932-25-007303
Chunk: 282

Company: XERIANT, INC.
Filing Date: 2025-10-02
Form: 10-K
Item: Item 1C
Chunk 282
---
SPEs).

Critical Accounting Policies

Our discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these consolidated financial statements requires us to make estimates and judgments which affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures of contingent assets and liabilities (see Note 2, Summary of Significant Accounting Policies, contained in the notes to the Company’s consolidated financial statements for the years ended June 30, 2025 and 2024 contained in this filing). On an ongoing basis, we evaluate our estimates. We base our estimates on historical experience and on various other assumptions which we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities which are not readily apparent from other sources. Actual results may differ from these estimates based upon different assumptions or conditions; however, we believe that our estimates are reasonable.

Management is aware that certain changes in accounting estimates employed in generating financial statements can have the effect of making the Company look more or less profitable than it actually is. Management does not believe that the Company has made any such changes in accounting estimates.

 34Table of Contents

Item 8. Financial Statements and Supplementary Data

XERIANT, INC. 

CONSOLIDATED FINANCIAL STATEMENTS 

JUNE 30, 2025 and 2024

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

Report of Independent Registered Public Accounting Firm (PCAOB ID # 6920) F-1     Consolidated Balance Sheets as of June 30, 2025 and 2024 F-3   Consolidated Statements of Operations for the Years Ended June 30, 2025 and 2024 F-4   Consolidated Statements of Stockholders’ Deficit for the Years Ended June 30, 2025 and 2024 F-5   Consolidated Statements of Cash Flows for the Years Ended June 30, 2025 and 2024 F-6   Notes to Consolidated Financial Statements F-7 

 35Table of Contents

To the Board of Directors and

Stockholders of Xeriant, Inc.

Opinion on the Financial Statements

We have audited the accompanying consolidated balance sheets of Xeriant, Inc. (the Company) as of June